PDS Biotechnology Corp (PDSB) operating KPIs
PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.44−0.11 (-7.10%)
Close on Oct 30, 2026Market cap $80.60MP/E –Yield –
KPIs
Operating metrics that drive PDS Biotechnology's business
| Rentable area (sq ft) | Q3 24 | Q2 24 | Q1 24 | Q3 23 | Q2 23 | Q1 23 | Q3 22 | Q2 22 | Q1 22 | Q3 21 | Q2 21 | Q1 21 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rentable area | 11,200 | 11,200 | 11,200 | 11,200 | 11,200 | 11,200 | 11,200 | 11,200 | 11,200 | 11,200 | 11,200 | 11,200 | 0.0% |
Counts and sizes PDS Biotechnology tags in the notes of its 10-K and 10-Q filings (XBRL), as of the end of each quarter. Breakdowns follow the company's own labels; at most 15 are shown per metric. A fuller KPI sheet built from earnings releases and presentations is on the way. See how companies compare on these metrics.